Risk factors for cardiovascular events in patients with heterozygous familial hypercholesterolaemia: protocol for a systematic review
María Elena Mansilla-Rodríguez(Hospital Universitario Infanta Leonor), Gerald F. Watts(Royal Perth Hospital), Alina Rigabert(Hospital Juan Ramón Jiménez), José Luis Sánchez‐Ramos(Universidad de Huelva), Eva Nadiedja Gutierrez-Cortizo(Hospital Universitario Infanta Leonor), Manuel Jesús Romero-Jiménez(Hospital Universitario de Valme), Pedro Mata(Hispanics in Philanthropy), Jing Pang(The University of Western Australia)
Cited by 4
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k